Intra-mesenteric steroids for steroid-refractory graft-versus-host disease in pediatric patients: A safe option
Abstract
Introduction. Graft-versus-host disease is a serious complication after hematopoietic stem cell transplantation and is a major cause of death post-transplantation. Approximately 50% of acute graft-versus-host disease patients do not respond to systemic steroids and their prognosis is poor regardless of the treatment. This study describes our experience with pediatric patients diagnosed with steroid-refractory graft-versus-host disease who received intra-mesenteric steroid treatment.
Objective. To determine the outcomes of intra-mesenteric steroid use in the management of pediatric patients diagnosed with refractory graft-versus-host disease.
Materials and methods. The study included patients under 18 years old with allogeneic hematopoietic stem cell transplantation who underwent intra-mesenteric steroid injection for resistant gastrointestinal graft-versus-host disease between January, 2016, and December, 2021. Methylprednisolone was administered via intra-arterial injection through the celiac trunk and the superior and inferior mesenteric arteries.
Results. We collected data on 21 patients: nine (90%) responded with a subjective decrease in fecal output and a reduction in bilirubin and transaminases. Seven patients required a second intra-mesenteric injection and presented a complete response in 85% of the cases. Only one patient experienced local complications after the procedure. Twelve patients (57%) died with one death due to acute graft-versus-host disease.
Conclusion. Reports in the adult population have shown an approximately 50% response rate with few complications, making it a second-line management standard. As far as we know, this is the largest pediatric cohort reported in Latin America. Our findings suggest that intra-mesenteric steroid administration for managing hepatic and gastrointestinal graftversus-host disease may be considered an early adjuvant treatment in patients with steroidrefractory graft-versus-host disease.
Downloads
References
Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: A joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood. 2005;106:1495-500. https://doi.org/10.1182/blood-2004-11-4557
Nishimoto M, Koh H, Hirose A, Nakamae M, Nakane T, Hayashi Y, et al. Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graftversus-host disease. Exp Hematol. 2015;43:995-1000. https://doi.org/10.1016/j.exphem.2015.08.002
Atilla E, Ataca Atilla P, Cengiz Seval G, Bektaş M, Demirer T. Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation. Turk J Gastroenterol. 2019;30:122-31. https://doi.org/10.5152/tjg.2018.18156
Shapira MY, Klimov A, Vipul S, Grisariu S, Avni BR, Or R, et al. Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD. Bone Marrow Transplant. 2017;52:1416-22. https://doi.org/10.1038/bmt.2017.120
Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, et al. A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment. Blood. 1991;77:1821-8.
Tamaki M, Nakasone H, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, et al. Outcome of gastrointestinal graft-versus-host disease according to the treatment response. Ann Hematol. 2018;97:1951-60. https://doi.org/10.1007/s00277-018-3385-7
Ramachandran V, Kolli SS, Strowd LC. Review of graft-versus-host disease. Dermatol Clin. 2019;37:569-82. https://doi.org/10.1016/j.det.2019.05.014
Xhaard A, Rocha V, Bueno B, de Latour RP, Lenglet J, Petropoulou A, et al. Steroidrefractory acute GVHD: Lack of long-term improved survival using new generation anticytokine treatment. Biol Blood Marrow Transplant. 2012;18:406-13. https://doi.org/10.1016/j.bbmt.2011.06.012
Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18:1150-63. https://doi.org/10.1016/j.bbmt.2012.04.005
Pidala J, Kim J, Perkins J, Field T, Fernández H, Pérez L, et al. Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease. Bone Marrow Transplant. 2010;45:919-24. https://doi.org/10.1038/bmt.2009.252
Mohty M, Holler E, Jagasia M, Jenq R, Malard F, Martin P, et al. Refractory acute graftversus-host disease: A new working definition beyond corticosteroid refractoriness. Blood. 2020;136:1903-6. https://doi.org/10.1182/blood.2020007336
Williams KM, Inamoto Y, Im A, Hamilton B, Koreth J, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report. Transplant Cell Ther. 2021;27:452-66. https://doi.org/10.1016/j.jtct.2021.02.035
Weintraub JL, Belanger AR, Sung CC, Stangl PA, Nowakowski FS, Lookstein RL. Intraarterial methylprednisolone infusion in treatment-resistant graft-versus-host disease. Cardiovasc Intervent Radiol. 2010;33:509-12. https://doi.org/10.1007/s00270-009-9792-3
Bürgler D, Medinger M, Passweg J, Fischmann A, Bucher C. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD. Leuk Res. 2014;38:184-7. https://doi.org/10.1016/j.leukres.2013.10.024
Bérczi V, Tóth A, Tatai G, Fábián J, Reményi P, Masszi T. Effectiveness of intra-arterial steroid administration for the treatment of steroid-refractory acute gastrointestinal graftversus-host disease. Clin Radiol. 2019;74:301-5. https://doi.org/10.1016/j.crad.2018.11.013
Shapira MY, Bloom AI, Or R, Sasson T, Nagler A, Resnick IB, et al. Intra-arterial catheter directed therapy for severe graft-versus-host disease. Br J Haematol. 2002;119:760-4. https://doi.org/10.1046/j.1365-2141.2002.03923.x
Nakai K, Tajima K, Tanigawa N, Matsumoto N, Zen K, Nomura S, et al. Intra-arterial steroidinjection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography. Bone Marrow Transplant. 2004;33:1231-3. https://doi.org/10.1038/sj.bmt.1704523
Tfayli A, Selby G, Maqbool F, Bierbaum W, Hamadani M. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versushost disease. Am J Hematol. 2006;81:959-62. https://doi.org/10.1002/ajh.20711
Sato T, Sakamaki S, Nagaoka Y, Kuribayashi K, Nagamachi Y, Morii K, et al. Intramesenteric artery steroid administration relieved severe refractory gastrointestinal graftvs-host disease in an allogeneic bone marrow transplantation patient. Am J Hematol. 1997;56:277-80. https://doi.org/10.1002/(sici)1096-8652(199712)56:4<277::aid-ajh14>3.0.co;2-6
Bhuller KS, Heran MKS, Wu JKM, Rassekh SR. Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease. Pediatr Blood Cancer. 2014;61:2321-3. https://doi.org/10.1002/pbc.25155
Al-Homsi AS, Roy TS, Cole K, Feng Y, Duffner U. Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21:604-11. https://doi.org/10.1016/j.bbmt.2014.08.014
Kanda Y, Hyo R, Yamashita T, Fujimaki K, Oshima K, Onoda M, et al. Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor. Am J Hematol. 2006;81:838-44. https://doi.org/10.1002/ajh.20710
Bilgin AU, Topcuoǧlu P, Sancak T, Konuk N, Arat M. Intramesenteric steroid treatment for steroid-refractory gastrointestinal graft versus host disease. Turk J Haematol. 2012;29:409-12. https://doi.org/10.5505/tjh.2012.57855
Berger M, Biasin E, Saglio F, Fagioli F. Innovative approaches to treat steroid-resistant or steroid refractory GVHD. Bone Marrow Transplant. 2008;42(Suppl.2):S101-5. https://doi.org/10.1038/bmt.2008.294
Martin PJ. Study design and endpoints in graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21:357-72. https://doi.org/10.1016/j.beha.2008.03.001
Hiramatsu K, Asakura H, Baba S. Selective intraarterial steroid injection in ulcerative colitis. Acta Radiol Diagn (Stockh). 1976;17:229-304.
Zhang MY, Zhao P, Zhang Y, Wang JS. Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: Systematic review and meta-analysis of randomised and nonrandomised studies. PLoS ONE. 2022;17:e0271979. https://doi.org/10.1371/journal.pone.0271979
Some similar items:
- Paula Ximena Pavía, Nubia Lucía Roa, Ana María Uribe, Concepción Judith Puerta, Using S35-S36 and TcH2AF-R primer-based PCR tests to follow-up a Chagas’ disease patient who had undergone a heart transplant , Biomedica: Vol. 31 No. 2 (2011)
- John F. Arboleda, Luis F. García, Cristiam M. Álvarez, ILT3+/ILT4+ tolerogenic dendritic cells and their influence on allograft survival , Biomedica: Vol. 31 No. 2 (2011)
- Ángela M. Pedraza, Carlos E. Rodríguez-Martínez, Ranniery Acuña, Initial validation of a scale to measure the burden for parents/caregivers of children with asthma and factors associated with this burden in a population of asthmatic children , Biomedica: Vol. 33 No. 3 (2013)
- Jairo Lizarazo, Edgar Parra, Patricia Gutiérrez, Carlos Mora, Juan Vargas, Idiopathic hypertrophic cranial pachymeningitis. , Biomedica: Vol. 24 No. 2 (2004)
- Marcela González, Claudia Patricia González, Alvaro Sanabria, Ultrasonographic estimation of the normal volume of the thyroid gland in pediatric populations. , Biomedica: Vol. 26 No. 1 (2006)
- Mario García, Liliana Alejandra Chicaíza, Hoover Quitián, Adriana Linares, Óscar Ramírez, Cost-effectiveness of consolidation treatments for acute myeloid leukemia in high-risk pediatric patients within the Colombian healthcare system , Biomedica: Vol. 35 No. 4 (2015)
- Wilson Daza, Silvana Dadan, Michelle Higuera, Profile of gastrointestinal diseases in a pediatric gastroenterology center in Colombia: 15 years of follow-up , Biomedica: Vol. 37 No. 3 (2017)
- Yazmin Rocío Arias, Karime Osorio-Arango, Brayan Bayona, Guadalupe Ercilla, Mauricio Beltrán-Durán, Determination of HLA-A, -B and -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014 , Biomedica: Vol. 37 No. 2 (2017)
- Luisa F. Imbachi, Lina M. Ibañez , Paula Hurtado-Villa, Health status and barriers in health care for children with birth defects born between 2011 and 2017 in two institutions in Cali , Biomedica: Vol. 40 No. 1 (2020)
- Lina Echeverri-Toro, Andrés Arango, Sigifredo Ospina, Carlos Agudelo, Bordetella bronchiseptica recurrent bacteraemia in a patient with bone marrow transplantation , Biomedica: Vol. 35 No. 3 (2015)

Copyright (c) 2024 Biomedica

This work is licensed under a Creative Commons Attribution 4.0 International License.
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |